Paasa Logo
Trinity Biotech plc logo
TRIBNASDAQMarket closedOpens 9:30am ET

Trinity Biotech plc

$6.72Last updated
-$0.04 (0.59%)Past day
Timezone

Trinity Biotech plc (NASDAQ: TRIB) is trading at $6.72, about ₹646 at today's USD/INR rate, as of 28 Sep 2026, 4:00 PM ET, down 0.59% today. Indian residents can buy Trinity Biotech from India on Paasa under the RBI's Liberalised Remittance Scheme.

Quote

Open:$7.29
Previous close:$6.76
Volume:2.43K

Today's low

$6.72

Today's high

$7.29

52 week low

$6.62

52 week high

$52.50

TRIB opened at $7.29, closed previously at $6.76, and has traded between $6.62 and $52.50 over the past 52 weeks.

About

Trinity Biotech plc, an Irish enterprise founded in 1992 and headquartered in Bray, is engaged in the acquisition, development, manufacturing, and global distribution of medical diagnostic solutions. The company's reach extends to the Americas, Africa, Asia, and Europe, catering to both clinical laboratory and point-of-care diagnostic markets. Its extensive range of clinical laboratory offerings encompasses diagnostic tests and specialized instrumentation for identifying numerous infectious diseases. These include Lyme disease, sexually transmitted infections like syphilis and herpes, SARS-CoV-2, and a variety of viral pathogens such as Epstein Barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, and varicella. Additionally, Trinity Biotech provides in-vitro diagnostic products centered on haemoglobin A1c for the crucial monitoring, diagnosis, and risk assessment of diabetes. The company's product development incorporates diverse assay formats, including immunofluorescence, enzyme-linked immunosorbent (ELISA), Western blot, and line immunoassays. It also supplies a suite of reagent products, including ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase, vital for diagnosing liver and kidney disorders, as well as haemolytic anaemia. Beyond diagnostics, Trinity Biotech serves the life sciences industry and research facilities by supplying raw materials. The company's customer base comprises public health authorities, non-governmental organizations, and both clinical and reference laboratories. Its products are distributed through a dedicated direct sales force, complemented by a broad network of independent distributors and strategic partnerships.

Country
IE
CEO
John Gillard
Exchange listed on
NASDAQ
Industry
Medical - Specialties
Base currency
USD
Full Time Employees
287
Sector
Healthcare
IPO date
21/10/1992

Key statistics

Avg. volume

41.28K

Market cap

$136.09M

P/E Ratio

-0.11

Price-to-sales ratio

3.10

Enterprise value

$268.93M

Free cash flow yield

-4.66%

Debt-to-equity ratio

-1.92

Return on equity

68.09%

ROIC

-15.05%

Beta

0.97

Dividend yield

0.00%

Last dividend

$0.00

Financial overview

Revenue

$43.78M

Earnings per share

-$60.00

Free cash flow

-$12.15M

Net profit margin

-85.32%

Gross margin

35.40%

EBITDA

-$21.38M

Revenue growth

-28.87%

Similar securities

This is not an investment recommendation

How to buy Trinity Biotech from India

Indian residents can buy Trinity Biotech shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.

  1. Open a Paasa account

    Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.

  2. Add funds under LRS

    Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars.

  3. Search for Trinity Biotech and place an order

    Find Trinity Biotech by name or by its ticker, TRIB, and choose an order type. You can buy by amount or by quantity — fractional shares mean there is no minimum trade size. Trinity Biotech trades 7:00 pm – 1:30 am IST; orders can only execute during that window.

  4. Track holdings and download tax reports

    Follow your Trinity Biotech position in USD and INR. Trinity Biotech pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.

Read the full guide: how to invest in Trinity Biotech from India

Trading and taxes when buying Trinity Biotech from India

Trading and limits

Trading hours
9:30 am – 4:00 pm ET
LRS limit
$250,000Per financial year, under the RBI's Liberalised Remittance Scheme.

Tax for Indian residents

TCS on remittance
20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
Capital gains in India
12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
Dividends
NoneTrinity Biotech does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained

Custody. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

FAQs

Can Indian residents buy Trinity Biotech stock?

Yes. Trinity Biotech (TRIB) has been listed on NASDAQ since 1992, in the Medical - Specialties industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars. Shares are held in your own name at Interactive Brokers LLC and are SIPC-insured up to $500,000 in total, including $250,000 for cash.

How much does one Trinity Biotech share cost in rupees?

One Trinity Biotech share is $6.72 — about ₹646 at a USD/INR rate of 96.07 on 28 Sep 2026. Both the Trinity Biotech price and the rupee rate move during the day, so the rupee cost changes with them.

What are the LRS and TCS rules for buying Trinity Biotech from India?

Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.

Can I buy whole shares of Trinity Biotech?

Yes. One Trinity Biotech share is $6.72, and you can buy as many whole shares as you like. You can also buy by amount rather than by quantity: there is no minimum trade size, and Paasa supports fractional investing in Trinity Biotech.

How are gains on Trinity Biotech shares taxed in India?

The US does not levy capital gains tax on shares for Indian residents, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the USD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Trinity Biotech price. Paasa issues a capital-gains statement for your return.

Does Trinity Biotech pay a dividend?

No. Trinity Biotech does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.

When can I trade Trinity Biotech from India?

NASDAQ trades 7:00 pm – 1:30 am IST in Indian time, so the close lands after midnight. The window shifts to 8:00 pm – 2:30 am IST when the US is on standard time. Orders can only execute during that window.

Is Trinity Biotech a United States company, and does that change how it is taxed?

Trinity Biotech trades on NASDAQ in US dollars, but the company is domiciled in Ireland. Trinity Biotech trades as an American Depositary Receipt rather than an ordinary share. Some non-US companies list in the US through American Depositary Receipts, which can carry dividend withholding at the company's home-country rate. Your India-side capital-gains treatment is the same either way.

Do I have to declare Trinity Biotech shares in my Indian tax return?

Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Trinity Biotech holding, its cost and its closing value.

How do I sell Trinity Biotech and bring the money back to India?

You sell during market hours (7:00 pm – 1:30 am IST) and the proceeds settle in USD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.